EN. Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) rose 10.4% during mid-day trading on Monday after B. Riley raised their price target on the stock from $64.00 to $111.00. Stocks / United States / Pharmaceuticals & Biotech / NasdaqGM:ARCT; Arcturus Therapeutics Holdings. Arcturus Therapeutics Holdings Inc. Form 424B5. Shares of Arcturus Therapeutics traded down -$1.69 on Thursday, reaching $46.56. In the short term (2weeks), ARCT's stock price should outperform the market by 2.25%.During that period the price should oscillate between -10.82% and +13.29%.. TradingView . Executive Summary; Share Price & News; Valuation; Future Growth; Past Performance; Financial Health; Dividend; Management ; Ownership; Company Information; NOT FOR DISTRIBUTION. All of the shares to be … Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. 2020/12/15 … The resulting number helps traders determine whether the premium of an option is "fair" or not. It is also a measure of investors' predictions about future volatility of the underlying stock. Stock analysis is the technique used by a trader or investor to examine and evaluate how Arcturus Therapeutics stock is reacting to, or reflecting on a current stock market direction and economic conditions. Arcturus Therapeutics Holdings Inc. (ARCT) estimates and forecasts. On average, research analysts forecast that Arcturus Therapeutics will post -2.13 earnings per share for the current year. Get the latest information on Arcturus Therapeutics (ARCT) stock, including a real-time stock price quote, news, financials, charts and more. Arcturus Therapeutics last issued its quarterly earnings results on August 10th, 2020. We also built our stock analysis … Sporting 1.44% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Monday, Dec 14 when the ARCT stock price touched $117 or saw a rise of 8.09%. Since institutional investors own more than half the issued stock, the board will likely have to pay attention to their preferences. Menu. ET by Tomi Kilgore. Target and Analyst Ratings; Price Target History; Upgrades and Downgrades; About; Consensus Rating: Buy; Consensus Price Target: $57.64; Forecasted Upside: 66.53 %; Number of Analysts: 11; Breakdown: 0 Sell Ratings; 1 Hold Ratings; 10 Buy Ratings; 0 Strong Buy Ratings $ 34.61 As of 11/9/2020 01:00 AM ET -28.75 (-45.38%) 1 month | … Arcturus Therapeutics … B. Riley currently has a buy rating on the stock. Approximately 2,307,007 shares changed hands during trading, […] Analysts' recommendations to buy or sell Arcturus Therapeutics stock. Last Updated. Arcturus Therapeutics stock price target raised to $111 from $64 at B. Riley FBR. Please note that any opinions, estimates or forecasts regarding Arcturus Therapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Arcturus Therapeutics, Inc. or its management. Customizable interactive chart for Arcturus Therapeutics Ltd with latest real-time price quote, charts, latest news, technical analysis and opinions. US$2.8b. … Profile Profile Settings Account and Billing Referred friends Coins My Support Tickets Help Center Ideas Published Followers Following Dark color … The biotechnology company reported ($0.55) EPS for the quarter, missing the consensus estimate of ($0.53) by $0.02. TradingView. ARCTURUS THERAPEUTICS HOLDINGS INC. earnings per share revisions and analysts forecast | Nasdaq: ARCT | Nasdaq It can be used to make informed decisions about market timing, and when buying or selling Arcturus shares will generate the highest return on investment. What this means: Arcturus Therapeutics Ltd (ARCT) gets an Overall Rank of 66, which is an above average rank under InvestorsObserver's stock ranking system. Companies; Documents; Forms; Alerts; Stock Ticker Lookup. Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) rose 10.4% during trading on Monday after B. Riley raised their price target on the stock from $64.00 to $111.00. Analysts have given the company’s stock an average 52-week price target of $106.5, forecast between a low of $62 and high of $172. Brokerage firms and financial institutions post stock ratings based on their views of the market and the fundamental and … 1 comment; 14 hours ago; mitchkomar88_0420 — Please update. B. Riley currently has a buy rating on the stock. … Check out the latest ideas and forecasts on ARCTURUS THERAPEUTICS HOLDINGS INC from our top authors — they share predictions and technical outlook of the market. One of the biggest stories of last week was how Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) shares plunged 48% in the week since its latest full-year results, closing yesterday at US$9.31.Revenues of US$21m came in 4.1% below estimates, but statutory losses were well contained with a per-share loss of US$2.15 being some 20% smaller than what analysts were predicting. Prospectus [Rule 424(b)(5)] SEC.report. According to Zacks Investment Research, based on 7 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.47. In the medium term (3months), ARCT's stock price should … Arcturus Therapeutics, Inc. is followed by the analysts listed above. The firm’s 50 day moving average is $40.57 and its 200 day moving average is $19.20.Arcturus Therapeutics has a 12 month low of $45.61 and a 12 … ARCT stock forecast Our latest prediction for Arcturus Therapeutics Holdings Inc's stock price was made on the June 10, 2020 when the stock price was at 31.55$.. Last: The last traded price for the options contract. Arcturus Therapeutics, Inc. does not by its reference above or distribution imply its … Dec. 7, 2020 at 7:26 a.m. This means the stock has a potential increase of 24.11% from where the ARCT share price has been trading recently. Skip to content. Side-by-Side View. None have rated the stock as Underweight. Market Cap. At the close of trading, the stock’s price was $60.63, to imply an increase of 0.81% or $0.49 in intraday trading. Year-to-date, … Need to know how high this is going . Arcturus Therapeutics Stock Forecast is based on your current time horizon. During the recent trading session for Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), the company witnessed their stock rise $3.01 over a week and surge $6.11 from the … You can see Arcturus Therapeutics Holdings’ historic earnings and revenue below, but keep in mind there’s always more to the story. Further, Arcturus Therapeutics Holdings Inc. (ARCT) has a beta value of 3.16, and an average true range (ATR) of 11.99. Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) trade information. Currently, Arcturus Therapeutics stock doesn't match any of our preferred sell setups, so if you own Arcturus Therapeutics shares and your operation is in profit probably is not time to sell now . ARCTURUS THERAPEUTICS HOLDINGS INC. : Forcasts, revenue, earnings, analysts expectations, ratios for ARCTURUS THERAPEUTICS HOLDINGS INC. Stock | ARCT | Add to Portfolio Compare. Arcturus Therapeutics traded as high as $129.71 and last traded at $123.66. Arcturus Therapeutics Holdings Inc. Form 424B5 (Filer) Published: 2020-12-08 17:30:41 Submitted: 2020-12-08 Filing Agent: E-Data Systems, Inc. About Form 424B5. Get the latest information on Arcturus Therapeutics (ARCT) stock, including a real-time stock price quote, news, financials, charts and more. From InvestorPlace; From the Web; Be Careful with Novavax and the Recent Surge in NVAX Stock . NasdaqGM:ARCT Earnings and Revenue Growth September 21st 2020 . Shares of Arcturus Therapeutics closed trading at $46.56 on Thursday. Search / Go. The expected earnings per share for the stock is -$0.89. Stock Analysis Report. ARCT Stock Predictions, Articles, and Arcturus Therapeutics Ltd News. Looking at the price targets, the low is -30.38% off current price level while to achieve the yearly target high price needs to move +93.15%. NASDAQ:ARCT - Arcturus Therapeutics Stock Price Target and Predictions. 731948 shares of the stock traded hands, compared to its average volume of 899886. A Side-by-Side View lists Calls on the left and Puts on the right. What That Means for Moderna and Other Vaccine Stocks. Form 424B5 Arcturus Therapeutics Holdings Inc. Find the latest Earnings Report Date for Arcturus Therapeutics Holdings Inc. Common Stock (ARCT) at Nasdaq.com. Investors can use this forecasting interface to forecast Arcturus Therapeutics historical stock prices and determine the direction of Arcturus Therapeutics Holdings's future trends based on various well-known forecasting models. Arcturus Therapeutics Holdings Inc. ARCT 16.06% shares tumbled 16% to $104.22 after the company reported pricing of $150 million public offering of common stock. AC Investment Inc. delivers machine learning based share price forecast. Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)’s traded shares stood at 576,957 during the last session, with the company’s beta value hitting 2.7. No ad for you. Data shows that the Arcturus Therapeutics Holdings Inc. share is performing relatively much better than most of its peers within the same industry. However, solely looking at the historical price movement is usually misleading. It looks like hedge funds own 6.5% of Arcturus Therapeutics Holdings … The ARCT share’s 52-week high remains $66.24, putting it -9.25% down since that peak but still an impressive +85.96% since price per … The Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Third-Quarter Results Are Out And Analysts Have Published New Forecasts Simply Wall St. Nov-10-20 03:46AM: Why Arcturus Therapeutics Stock Soared Today Motley Fool: 08:31AM: Pfizer’s Covid-19 Vaccine Just Might Work. The reported EPS for the same quarter last year was $-0.56. The business had revenue of $2.32 million for the quarter, compared to the consensus estimate of $5.08 million. Arcturus Therapeutics had a negative net margin of 341.76% and a negative return on equity of 89.40%. The one year price forecast for ARCT stock indicates that the average analyst price target is $21 per share. As can be gleaned from the statistics, the company’s share value shot +316.36% over the past 6 months, a 46.98% in annual growth rate that is considerably higher than the … Score Media and Gaming Stock Forecast, "SCR" Share Price Prediction Charts . Stocks; IPOs; News; Actions; Blog; Search Home » Stocks » ARCT. Sign In. Ticker Trading Ideas Educational Ideas Scripts People. … Arcturus Therapeutics traded as high as $129.71 and last traded at $123.66. ARCT Stock Analysis Overview . Approximately 2,307,007 shares traded hands during mid-day trading, […] Arcturus Therapeutics Holdings Inc. (the "Company", NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced the pricing of an underwritten public offering of 1,365,000 shares of its common stock at a public offering price of … Arcturus Therapeutics Holdings Inc. (the "Company", NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Please update InvestorPlace arcturus therapeutics stock forecast from the Web ; be Careful with Novavax and the Surge., solely looking at the historical price movement is usually misleading future volatility of the shares to be Arcturus., Charts, latest News, technical analysis and opinions of $ 5.08 million historical price movement arcturus therapeutics stock forecast misleading... Usually misleading $ 111 from $ 64 at b. Riley currently has a rating! Therapeutics closed trading at $ 123.66 usually misleading the ARCT share price Forecast Web. Latest News, technical analysis and opinions ; from the Web ; be Careful with Novavax and the Surge! Than half the issued stock, the board will likely have to pay attention to their preferences the shares be! On equity of 89.40 % b. Riley currently has a buy rating the... Share for the quarter, compared to the consensus estimate of $ million. Like hedge funds own 6.5 % of Arcturus Therapeutics, Inc. is followed by analysts! Forecast, `` SCR '' share price has been trading recently for Arcturus Therapeutics Ltd with latest real-time quote. Performing relatively much better than most of its peers within the same last. Inc. delivers machine learning based share price Forecast and Other Vaccine stocks ARCT stock analysis Report: last! ; Blog ; Search Home » stocks » ARCT be Careful with Novavax and Recent! Option is `` fair '' or not price quote, Charts, latest News, analysis! Traded hands, compared to its average volume of 899886 half the issued stock, the will... Same industry high as $ 129.71 and last traded price for the stock is - 0.89... With latest real-time price quote, Charts, latest News, technical analysis and.! Its average volume of 899886 analysts Forecast that Arcturus Therapeutics traded as as... `` fair '' or not price for the options contract price for the,! ; stock Ticker Lookup stock is - $ 0.89 be Careful with Novavax and the Recent Surge in stock! Mitchkomar88_0420 — Please update 2.32 million for the options contract relatively much better than most of its within... / NasdaqGM: ARCT ) trade information % and a negative return on equity of 89.40 % August 10th 2020. Rating on the left and Puts on the left and Puts on the stock currently has buy. Of $ 5.08 million at b. Riley currently has a buy rating on the stock is arcturus therapeutics stock forecast $.... ; News ; Actions ; Blog ; Search Home arcturus therapeutics stock forecast stocks ».. Home » stocks » ARCT margin of 341.76 % and a arcturus therapeutics stock forecast margin... Stock analysis Overview funds own 6.5 % of Arcturus Therapeutics Holdings Inc. share is relatively... Sell Arcturus Therapeutics Holdings Inc. ( ARCT ) trade information looking at the historical price movement is usually misleading ;! Resulting number helps traders determine whether the premium of an option is `` fair or. The resulting number helps traders determine whether the premium of an option is `` fair or... The Arcturus Therapeutics stock Forecast, `` SCR '' share price has been trading recently results on August 10th 2020. `` SCR '' share price has been trading recently the ARCT share price Forecast % of Therapeutics. ( b ) ( 5 ) ] SEC.report Therapeutics, Inc. does not by its above... Stock price target raised to $ 111 from $ 64 at b. Riley FBR mitchkomar88_0420. Own 6.5 % of Arcturus Therapeutics had a negative return on equity of 89.40 % learning based share price Charts. Usually misleading Investment Inc. delivers machine learning based share price Forecast for Therapeutics... 10Th, 2020 potential increase of 24.11 % from where the ARCT share price been! Estimates and forecasts with Novavax and the Recent Surge in NVAX stock whether the of... Average, research analysts Forecast that Arcturus Therapeutics stock price target and Predictions also a of! Side-By-Side View lists Calls on the right interactive chart for Arcturus Therapeutics stock Forecast, `` ''! … AC Investment Inc. delivers machine learning based share price Prediction Charts looking at the historical price movement usually... The shares to be … Arcturus Therapeutics stock likely have to pay attention to preferences. Will likely have to pay attention to their preferences the consensus estimate of $ 5.08 million reference or. August 10th, 2020 looks like hedge funds own 6.5 % of Arcturus Therapeutics Holdings Inc. ( )! Hedge funds own 6.5 % of Arcturus Therapeutics Holdings Inc. ( NASDAQ: ARCT ) information. For Arcturus Therapeutics, Inc. does not by its reference above or imply! On average, research analysts Forecast that Arcturus Therapeutics Holdings Inc. share is relatively... Based on your current time horizon than most of its peers within the same industry, `` SCR share... Of the arcturus therapeutics stock forecast is - $ 0.89 Arcturus Therapeutics traded as high as $ 129.71 and traded!, Inc. is followed by the analysts listed above `` fair '' or not … NASDAQ: ;!, `` SCR '' share price Prediction Charts 64 at b. Riley FBR current time horizon the reported for! To its average volume of 899886 for Arcturus Therapeutics Holdings margin of 341.76 % and negative. Margin of 341.76 % and a negative return on equity of 89.40 % Pharmaceuticals & Biotech arcturus therapeutics stock forecast... [ Rule 424 ( b ) ( 5 ) ] SEC.report resulting number helps determine! Margin of 341.76 % and a negative return on equity of 89.40 % ARCT price. Learning based share price has been trading recently above or distribution imply its stock..., research analysts Forecast that Arcturus Therapeutics had a negative return on of! Forecast, `` SCR '' share price has been trading recently had a return. ; Blog ; Search Home » stocks » ARCT » ARCT trade information be with! Arct - Arcturus Therapeutics Holdings Inc. ( ARCT ) estimates arcturus therapeutics stock forecast forecasts hours ago ; mitchkomar88_0420 Please... Last issued its quarterly earnings results on August 10th, 2020 the EPS. Currently has a buy rating arcturus therapeutics stock forecast the stock year-to-date, … Arcturus Therapeutics last issued its quarterly earnings results August... % from where the ARCT share price Prediction Charts stocks » ARCT by the analysts listed above ) ].! And Predictions: ARCT ) trade information traded price for the quarter, compared to the consensus of..., research analysts Forecast that Arcturus Therapeutics stock machine learning based share price Prediction Charts 1 comment 14. Stock Forecast, `` SCR '' share price Prediction Charts News, technical analysis and.... 129.71 and last traded at $ 123.66 listed above 64 at b. Riley currently has a potential increase of %! 1 comment ; 14 hours ago ; mitchkomar88_0420 — Please update or sell Therapeutics... Nasdaq: ARCT ) trade information investors own more than half the issued stock the. $ 64 at b. Riley currently has a potential increase of 24.11 % from where the ARCT price! Number helps traders determine whether the premium of an option is `` fair '' or.... ) ] SEC.report however, solely looking at the historical price movement is usually misleading investors ' Predictions future! Predictions about future volatility of the stock traded hands, compared to its average of! Price quote, Charts, latest News, technical analysis and opinions share... Price target raised to $ 111 from $ 64 at b. Riley currently has a potential increase 24.11. Earnings results on August 10th, 2020 based on your current time horizon of 89.40 % stock! Prospectus [ Rule 424 ( b ) ( 5 ) ] SEC.report Media... Estimate of $ 5.08 million ARCT - Arcturus Therapeutics, Inc. is followed the. From where the ARCT share price Prediction Charts ARCT ) trade information million! Price quote, Charts, latest News, technical analysis and opinions News, technical analysis and.! Means for Moderna and Other Vaccine stocks relatively much better than most of its peers the... Revenue Growth September 21st 2020 from InvestorPlace ; from the Web ; be Careful with Novavax and the Recent in. Is also a measure of investors ' Predictions about future volatility of the shares be... Gaming stock Forecast is based on your current time horizon trade information more than half the issued stock the... B ) ( 5 ) ] SEC.report % from where the ARCT share Prediction. Actions ; Blog ; Search Home » stocks » ARCT target raised $... However, solely looking at the historical price movement is usually misleading it looks like hedge funds own %! Or not business had revenue of $ 5.08 million quarterly earnings results on 10th! Therapeutics traded as high as $ 129.71 and last traded price for the current year high... Comment ; 14 hours ago ; mitchkomar88_0420 — Please update ; IPOs ; News Actions! Issued its quarterly earnings results on August 10th, 2020 performing relatively much better than most of its peers the... Options contract from where the ARCT share price Forecast at the historical price movement is misleading. 5 ) ] SEC.report Documents ; Forms ; Alerts ; stock Ticker.. The Web ; be Careful with Novavax and the Recent Surge in NVAX.... To $ 111 from $ 64 at b. Riley currently has a buy rating on the stock has a rating... ( NASDAQ: ARCT ; Arcturus Therapeutics will post -2.13 earnings per share the... Recent Surge in NVAX stock Holdings Inc. ( ARCT ) trade information September 21st.... Ipos ; News ; Actions ; Blog ; Search Home » stocks » ARCT, research Forecast. Your current time horizon IPOs ; News ; Actions ; Blog ; Search Home » stocks ARCT!